Chronic Daily Headache denials in California external review

In the California DMHC record, independent physician reviewers decided 25 published external-review cases involving chronic daily headacheand overturned the plan’s denial in 44%. That is a historical result among cases that reached this program, not a forecast for an individual appeal.

California DMHC decisions
25
2004–2025
Overturned
44%
11 denials reversed

Most-fought treatments for chronic daily headache

What insurers denied — and how those fights ended.
CategoryDecisionsOverturned
Botox Injections11
36.4%

What the insurer actually argued

Denials fall into different categories, and they don’t succeed equally — so the reason on your letter changes how you should answer it.
Reason givenDecisionsOverturned
Medical Necessity
The plan said the care wasn’t medically necessary. The most common fight, and the most winnable.
13
38.5%
Experimental/Investigational
The plan called the treatment unproven. These turn on published evidence, so the appeal is a literature argument.
11
54.5%
Typical time to a decision
18 days
Most land between 7 and 22 days
Handled as urgent
28%
Expedited when a delay would cause harm

What the reviewers wrote

Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.

Where the denial was overturned

Physician 1The patient is a 47-year-old female who has high blood pressure, migraines, chronic daily headaches, TMJ, constant tinnitus, ear pain, vertigo, and carpel tunnel syndrome. She also has dizziness and facial pain due to a work-related injury that occurred in May 1989. She has failed several medications including Periactin, Imitrex, Vicodin, and others. The patient received Botox injections for two years. She has requested authorization for additional Botox therapy. The Health Plan has denied her request on the basis that the requested therapy is considered experimental for treatment of the patient’s medical condition.The patient has a complex history with significant chronic migraine headaches. She has reportedly tried many medications without benefit. She has used Botox for two years with relief. Botox is now in common use for the treatment of headache.
Experimental/Investigational · 2004 · IMR EI04-3767
The patient’s parent has requested authorization and coverage for onabotulinumtoxinA (Botox) injections. Based on the available documentation and current medical literature, the requested Botox injections are medically necessary for treatment of this patient’s medical condition. The patient is already taking Prozac as an antidepressant, which is a relative contraindication to the addition of amitriptyline, a tricyclic antidepressant. Topiramate has the potential to worsen her depressive symptoms. Botox is a potent muscle relaxant, which has been found to have analgesic effects in patients with a variety of pain syndromes. Data from clinical trials have confirmed the efficacy, safety, and tolerability of Botox in the prophylactic treatment of chronic migraine in adults. The U.S. Food and Drug Administration approved Botox for the treatment of chronic migraine in 2010.
Medical Necessity · 2019 · IMR MN19-31712

Where the denial was upheld

Worth reading too — these show what an appeal has to overcome.
Nature of Statutory Criteria/Case Summary: An enrollee has requested medical services on an emergent or urgent basis. Findings: The physician reviewer found that at issue in this case is whether a prudent layperson in the patient’s circumstances would have sought immediate medical attention on the dates of service in dispute. California law defines an “emergency medical condition” as a medical condition manifesting itself by acute symptoms of sufficient severity (including severe pain) such that the absence of immediate medical attention could reasonably be expected to result in any of the following: (1) Placing the patient’s health in serious jeopardy; (2) Serious impairment to bodily functions; (3) Serious dysfunction of any bodily organ or part.
Urgent Care · 2016 · IMR UR16-23234
Physician 1The patient is a 23-year-old female who suffers from mixed headache syndrome and stress. The patient has been followed by a neurology clinic and was doing reasonably well with doses of Zomig but had untoward side effects. She was switched to Axert, which provided some relief. The notes indicate the patient has prolonged episodes of headaches. These appear to be muscle tension type headaches related to stress. She is also being treated with Zoloft. Because the patient is overweight and may have a mild thyroid deficiency, Depakote has not been tried. Calcium channel blockers have not been prescribed given the patient’s low blood pressure. The patient’s provider has recommended treatment with Botox.
Experimental/Investigational · 2004 · IMR EI04-3446

Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California external-review outcomes. Other state and federal programs have different eligibility rules, processes, and current availability; the rates here do not transfer to those programs or predict an individual result. Excerpts are quoted verbatim from the public record and describe this condition generally, not any individual case.

How to use this in your appeal

These outcomes describe eligible cases completed through California DMHC’s Independent Medical Review program. They do not estimate the chance that an internal appeal, an external review in another jurisdiction, or your individual case will succeed. Use the record to identify evidence patterns involving chronic daily headache, then check the rights and deadlines that apply to your plan.

SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · AGGREGATES + DEIDENTIFIED DECISION EXCERPTS/REFERENCE IDS · METHODOLOGY

Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.

Fighting a denial for chronic daily headache? Use the California record to prepare.

Explain my denial — freeStart my appeal · $9